Your browser doesn't support javascript.
loading
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Wortman, B G; Creutzberg, C L; Putter, H; Jürgenliemk-Schulz, I M; Jobsen, J J; Lutgens, L C H W; van der Steen-Banasik, E M; Mens, J W M; Slot, A; Kroese, M C Stenfert; van Triest, B; Nijman, H W; Stelloo, E; Bosse, T; de Boer, S M; van Putten, W L J; Smit, V T H B M; Nout, R A.
Afiliação
  • Wortman BG; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
  • Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Jobsen JJ; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Lutgens LCHW; Maastricht Radiation Oncology Clinic, Maastricht, The Netherlands.
  • van der Steen-Banasik EM; Radiotherapy Group, Arnhem, The Netherlands.
  • Mens JWM; Department of Radiation Oncology, Erasmus MC- Cancer Institute, Rotterdam, The Netherlands.
  • Slot A; Radiotherapy Institute Friesland, Leeuwarden, The Netherlands.
  • Kroese MCS; Radiotherapy Group, Deventer, The Netherlands.
  • van Triest B; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nijman HW; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Stelloo E; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Putten WLJ; Department of Biostatistics, ErasmusMC Cancer Institute, Rotterdam, The Netherlands.
  • Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Nout RA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands. r.a.nout@lumc.nl.
Br J Cancer ; 119(9): 1067-1074, 2018 10.
Article em En | MEDLINE | ID: mdl-30356126
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pelve / Vagina / Neoplasias do Endométrio / Radioterapia Adjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pelve / Vagina / Neoplasias do Endométrio / Radioterapia Adjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article